Markets › United States › NAS › SGMT

Sagimet Biosciences Inc

NAS:SGMTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$9.85−1.01%LiveIn session · ≈ AED 36.17 · Market cap $692.86M · Next earnings Thu 12 Nov

🔔 Alert▶ Test a strategy

Date	Name	Role	Type	Shares	Value
Fri, 14 Aug 2026	Kemble George	director	M-Exempt	326,618	$2.08M
Fri, 14 Aug 2026	Kemble George	director	M-Exempt	24,369	$154.99K
Fri, 14 Aug 2026	Kemble George	director	S-Sale	350,987	$3.59M
Fri, 14 Aug 2026	Kemble George	director	S-Sale	350,987	$3.59M
Fri, 14 Aug 2026	Kemble George	director	M-Exempt	24,369	$154.99K
Fri, 14 Aug 2026	Kemble George	director	M-Exempt	326,618	$2.08M
Tue, 11 Aug 2026	Kemble George	director	M-Exempt	9,751	$62.02K
Tue, 11 Aug 2026	Kemble George	director	M-Exempt	10,455	$66.49K
Tue, 11 Aug 2026	Kemble George	director	S-Sale	20,206	$201.15K
Tue, 11 Aug 2026	Kemble George	director	S-Sale	20,206	$201.15K
Tue, 11 Aug 2026	Kemble George	director	M-Exempt	10,455	$66.49K
Tue, 11 Aug 2026	Kemble George	director	M-Exempt	9,751	$62.02K
Mon, 20 Jul 2026	Kemble George	director	S-Sale	18,844	$140.53K
Mon, 20 Jul 2026	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	S-Sale	10,545	$81.83K
Mon, 20 Jul 2026	Happel David	director, officer: President & CEO	S-Sale	64,051	$497.07K
Thu, 19 Feb 2026	Chauche Thierry	officer: Chief Financial Officer	A-Award	44,000	$0
Thu, 19 Feb 2026	Happel David	director, officer: President & CEO	A-Award	128,000	$0
Thu, 19 Feb 2026	Martins Eduardo Bruno	officer: Chief Medical Officer	A-Award	44,000	$0
Thu, 19 Feb 2026	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	A-Award	44,000	$0
Tue, 10 Feb 2026	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	S-Sale	2,622	$14.05K
Tue, 10 Feb 2026	Martins Eduardo Bruno	officer: Chief Medical Officer	S-Sale	3,640	$19.51K
Tue, 10 Feb 2026	Chauche Thierry	officer: Chief Financial Officer	S-Sale	1,312	$7.03K
Tue, 10 Feb 2026	Happel David	director, officer: President & CEO	S-Sale	12,101	$64.86K
Thu, 20 Nov 2025	Kemble George	director, officer: Executive Chairman	S-Sale	37,688	$289.82K
Tue, 4 Nov 2025	Rozek Elizabeth	officer: Chief Legal & Admin. Officer	A-Award	9,855	$0

Date

Name

Role

Type

Value

Fri, 14 Aug 2026

Kemble George

director

M-Exempt

326,618

$2.08M

Fri, 14 Aug 2026

Kemble George

director

M-Exempt

24,369

$154.99K

Fri, 14 Aug 2026

Kemble George

director

S-Sale

350,987

$3.59M

Fri, 14 Aug 2026

Kemble George

director

S-Sale

350,987

$3.59M

Fri, 14 Aug 2026

Kemble George

director

M-Exempt

24,369

$154.99K

Fri, 14 Aug 2026

Kemble George

director

M-Exempt

326,618

$2.08M

Tue, 11 Aug 2026

Kemble George

director

M-Exempt

9,751

$62.02K

Tue, 11 Aug 2026

Kemble George

director

M-Exempt

10,455

$66.49K

Tue, 11 Aug 2026

Kemble George

director

S-Sale

20,206

$201.15K

Tue, 11 Aug 2026

Kemble George

director

S-Sale

20,206

$201.15K

Tue, 11 Aug 2026

Kemble George

director

M-Exempt

10,455

$66.49K

Tue, 11 Aug 2026

Kemble George

director

M-Exempt

9,751

$62.02K

Mon, 20 Jul 2026

Kemble George

director

S-Sale

18,844

$140.53K

Mon, 20 Jul 2026

Rozek Elizabeth

officer: Chief Legal & Admin. Officer

S-Sale

10,545

$81.83K

Mon, 20 Jul 2026

Happel David

director, officer: President & CEO

S-Sale

64,051

$497.07K

Thu, 19 Feb 2026

Chauche Thierry

officer: Chief Financial Officer

A-Award

44,000

Thu, 19 Feb 2026

Happel David

director, officer: President & CEO

A-Award

128,000

Thu, 19 Feb 2026

Martins Eduardo Bruno

officer: Chief Medical Officer

A-Award

44,000

Thu, 19 Feb 2026

Rozek Elizabeth

officer: Chief Legal & Admin. Officer

A-Award

44,000

Tue, 10 Feb 2026

Rozek Elizabeth

officer: Chief Legal & Admin. Officer

S-Sale

2,622

$14.05K

Tue, 10 Feb 2026

Martins Eduardo Bruno

officer: Chief Medical Officer

S-Sale

3,640

$19.51K

Tue, 10 Feb 2026

Chauche Thierry

officer: Chief Financial Officer

S-Sale

1,312

$7.03K

Tue, 10 Feb 2026

Happel David

director, officer: President & CEO

S-Sale

12,101

$64.86K

Thu, 20 Nov 2025

Kemble George

director, officer: Executive Chairman

S-Sale

37,688

$289.82K

Tue, 4 Nov 2025

Rozek Elizabeth

officer: Chief Legal & Admin. Officer

A-Award

9,855

Holder	Shares	% out	Change
BlackRock, Inc.	6,575,788	9.3%	+5,775,845
Balyasny Asset Management L.P.	3,626,113	5.2%	—
Woodline Partners LP	3,000,652	4.3%	+1,999,709
SILVERARC CAPITAL MANAGEMENT, LLC	2,927,698	4.2%	—
VANGUARD CAPITAL MANAGEMENT LLC	2,566,272	3.6%	+1,467,353
BVF INC/IL	2,500,000	3.6%	—
Caligan Partners LP	2,500,000	3.6%	—
Affinity Asset Advisors, LLC	2,497,864	3.6%	+1,629,844
FEDERATED HERMES, INC.	2,086,715	3.0%	+2,085,934
GREAT POINT PARTNERS LLC	2,029,933	2.9%	—
STATE STREET CORP	1,995,092	2.8%	+1,866,304
Saturn V Capital Management LP	1,479,918	2.1%	—
GEODE CAPITAL MANAGEMENT, LLC	1,444,019	2.1%	+1,134,497
Blue Owl Capital Holdings LP

Holder

% out

Change

BlackRock, Inc.

6,575,788

9.3%

+5,775,845

Balyasny Asset Management L.P.

3,626,113

5.2%

—

Woodline Partners LP

3,000,652

4.3%

+1,999,709

SILVERARC CAPITAL MANAGEMENT, LLC

2,927,698

4.2%

—

VANGUARD CAPITAL MANAGEMENT LLC

2,566,272

3.6%

+1,467,353

BVF INC/IL

2,500,000

3.6%

—

Caligan Partners LP

2,500,000

3.6%

—

Affinity Asset Advisors, LLC

2,497,864

3.6%

+1,629,844

FEDERATED HERMES, INC.

2,086,715

3.0%

+2,085,934

GREAT POINT PARTNERS LLC

2,029,933

2.9%

—

STATE STREET CORP

1,995,092

2.8%

+1,866,304

Saturn V Capital Management LP

1,479,918

2.1%

—

GEODE CAPITAL MANAGEMENT, LLC

1,444,019

2.1%

+1,134,497

Blue Owl Capital Holdings LP

Sagimet Biosciences Inc

Sagimet Biosciences Inc

Insider activity

Institutional holders